+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Urinalysis Test Market Size, Share & Industry Trends Analysis Report By Product (Consumables and Instruments), By Application (Disease Screening and Pregnancy & Fertility), By End User, By Country and Growth Forecast, 2023-2029

  • PDF Icon

    Report

  • 92 Pages
  • April 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5806558
The Europe Urinalysis Test Market should witness market growth of 5.7% CAGR during the forecast period (2023-2029).

The urinalysis test is growing as a result of massive investments in the creation of urine testing kits for use at home in the diagnosis of diseases. In addition, the development of at-home urine tests is being pursued by organizations to offer advice on nutrition and lifestyle choices. For routine urine examinations, emerging nations with high price sensitivity favored affordable yet similarly functional analyzers. Thus, the creation of inexpensive urinalysis tests is anticipated to drive market expansion.

The test includes a number of microscopic, visual, and chemical tests that reveal cells, protein levels, creatinine levels, and elements like crystals in the urine that aid in the identification of various disorders. Finding the source of symptoms, including back pain, stomach pain, and painful urination, also helps. Additionally, it is projected that the expansion of the urinalysis market would be aided by factors such as an aging population, an increase in government activities to raise public awareness, and technological advancements in urinalysis.

Diabetes affects about 8.5 million people in Germany. This resulted from a review of the data from the Robert Koch Institute's survey and investigation across the country. Estimates say about 2 million people have diabetes but don't know it. Over the next twenty years, the number of people with type 2 diabetes in Germany will keep increasing. It is estimated that as many as 12 million people could have metabolic disorders by 2040. Thus, with the rising cases of diabetes, the demand for its diagnosis will also increase, providing more growth opportunities for the urinalysis test market growth.

The Germany market dominated the Europe Urinalysis Test Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $299.6 Million by 2029. The UK market is anticipated to grow at a CAGR of 4.7% during (2023-2029). Additionally, The France market would experience a CAGR of 6.6% during (2023-2029).

Based on Product, the market is segmented into Consumables and Instruments. Based on Application, the market is segmented into Disease Screening and Pregnancy & Fertility. Based on End-user, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Homecare. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Siemens Healthineers AG (Siemens AG), ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Arkray, Inc., Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Becton, Dickinson and Company.

Scope of the Study

By Product

  • Consumables
  • Instruments

By Application

  • Disease Screening
  • Pregnancy & Fertility

By End-user

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Homecare

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Cardinal Health, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • ACON Laboratories, Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Arkray, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Urinalysis Test Market, by Product
1.4.2 Europe Urinalysis Test Market, by Application
1.4.3 Europe Urinalysis Test Market, by End User
1.4.4 Europe Urinalysis Test Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Jan-2023, Apr) Leading Players
Chapter 4. Europe Urinalysis Test Market by Product
4.1 Europe Consumables Market by Country
4.2 Europe Instruments Market by Country
Chapter 5. Europe Urinalysis Test Market by Application
5.1 Europe Disease Screening Market by Country
5.2 Europe Pregnancy & Fertility Market by Country
Chapter 6. Europe Urinalysis Test Market by End User
6.1 Europe Diagnostic Laboratories Market by Country
6.2 Europe Hospitals & Clinics Market by Country
6.3 Europe Homecare Market by Country
Chapter 7. Europe Urinalysis Test Market by Country
7.1 Germany Urinalysis Test Market
7.1.1 Germany Urinalysis Test Market by Product
7.1.2 Germany Urinalysis Test Market by Application
7.1.3 Germany Urinalysis Test Market by End User
7.2 UK Urinalysis Test Market
7.2.1 UK Urinalysis Test Market by Product
7.2.2 UK Urinalysis Test Market by Application
7.2.3 UK Urinalysis Test Market by End User
7.3 France Urinalysis Test Market
7.3.1 France Urinalysis Test Market by Product
7.3.2 France Urinalysis Test Market by Application
7.3.3 France Urinalysis Test Market by End User
7.4 Russia Urinalysis Test Market
7.4.1 Russia Urinalysis Test Market by Product
7.4.2 Russia Urinalysis Test Market by Application
7.4.3 Russia Urinalysis Test Market by End User
7.5 Spain Urinalysis Test Market
7.5.1 Spain Urinalysis Test Market by Product
7.5.2 Spain Urinalysis Test Market by Application
7.5.3 Spain Urinalysis Test Market by End User
7.6 Italy Urinalysis Test Market
7.6.1 Italy Urinalysis Test Market by Product
7.6.2 Italy Urinalysis Test Market by Application
7.6.3 Italy Urinalysis Test Market by End User
7.7 Rest of Europe Urinalysis Test Market
7.7.1 Rest of Europe Urinalysis Test Market by Product
7.7.2 Rest of Europe Urinalysis Test Market by Application
7.7.3 Rest of Europe Urinalysis Test Market by End User
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Sysmex Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Cardinal Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.8 Danaher Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 ACON Laboratories, Inc.
8.9.1 Company Overview
8.10. Arkray, Inc.
8.10.1 Company Overview

Companies Mentioned

  • Cardinal Health, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • ACON Laboratories, Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Arkray, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company

Methodology

Loading
LOADING...